featured
Oral Teriflunomide for Patients With Relapsing Multiple Sclerosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Oral Teriflunomide for Patients With Relapsing Multiple Sclerosis (TOWER): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial
Lancet Neurol 2014 Mar 01;13(3)247-256, C Confavreux, P O'Connor, G Comi, MS Freedman, AE Miller, TP Olsson, JS Wolinsky, T Bagulho, JL Delhay, D Dukovic, P Truffinet, L KapposFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.